Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients

Avadhut D. Joshi, Rachel C. Botham, Lisa J. Schlein, Howard S. Roth, Antonella Mangraviti, Alexandra Borodovsky, Betty Tyler, Steve Joslyn, Jayme S. Looper, Michael Podell, Timothy M. Fan, Paul J. Hergenrother, Gregory J. Riggins

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients'. Together they form a unique fingerprint.

Medicine & Life Sciences